×
Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia: A Comprehensive Review of Recent Literature. PDF
$ 40.00
Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia: A Comprehensive Review of Recent Literature. PDF quantity
$ 40.00
×
Prevalence and Correlates of Clinically Significant Depressive Symptoms in an Urban Hospital Emergency Department PDF
$ 40.00
Prevalence and Correlates of Clinically Significant Depressive Symptoms in an Urban Hospital Emergency Department PDF quantity
$ 40.00
×
Lipid Disturbances in Adolescents Treated With Second-Generation Antipsychotics: Clinical Determinants of Plasma Lipid Worsening and New-Onset Hypercholesterolemia PDF
$ 40.00
Lipid Disturbances in Adolescents Treated With Second-Generation Antipsychotics: Clinical Determinants of Plasma Lipid Worsening and New-Onset Hypercholesterolemia PDF quantity
$ 40.00
×
Psychotherapy for Depression in Older Veterans Via Telemedicine: Effect on Quality of Life, Satisfaction, Treatment Credibility, and Service Delivery Perception PDF
$ 40.00
Psychotherapy for Depression in Older Veterans Via Telemedicine: Effect on Quality of Life, Satisfaction, Treatment Credibility, and Service Delivery Perception PDF quantity
$ 40.00
×
Bridging the Gap: An Educational Intervention to Enhance Mental Health Competency Among Primary and Specialty Care Providers PDF
$ 40.00
Bridging the Gap: An Educational Intervention to Enhance Mental Health Competency Among Primary and Specialty Care Providers PDF quantity
$ 40.00
×
Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study PDF
$ 40.00
Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study PDF quantity
$ 40.00
×
Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder PDF
$ 40.00
Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder PDF quantity
$ 40.00
×
Two-Year Outcome of Vagus Nerve Stimulation (VNS) for Treatment of Major Depressive Episodes PDF
$ 40.00
Two-Year Outcome of Vagus Nerve Stimulation (VNS) for Treatment of Major Depressive Episodes PDF quantity
$ 40.00
×
Treatment of Dysthymia With Sertraline: A Double-Blind, Placebo-Controlled Trial in Dysthymic Patients Without Major Depression PDF
$ 40.00
Treatment of Dysthymia With Sertraline: A Double-Blind, Placebo-Controlled Trial in Dysthymic Patients Without Major Depression PDF quantity
$ 40.00
×
Efficacy of Osmotic-Release Oral System (OROS) Methylphenidate for Mothers With Attention-Deficit/Hyperactivity Disorder (ADHD): Preliminary Report of Effects on ADHD Symptoms and Parenting PDF
$ 40.00
Efficacy of Osmotic-Release Oral System (OROS) Methylphenidate for Mothers With Attention-Deficit/Hyperactivity Disorder (ADHD): Preliminary Report of Effects on ADHD Symptoms and Parenting PDF quantity
$ 40.00
×
Effects of Milnacipran on Neurocognition, Pain, and Fatigue in Fibromyalgia: A 13-Week, Randomized, Placebo-Controlled, Crossover Trial PDF
$ 40.00
Effects of Milnacipran on Neurocognition, Pain, and Fatigue in Fibromyalgia: A 13-Week, Randomized, Placebo-Controlled, Crossover Trial PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart